Speakers:
Bob Inserra – Johnson & Johnson Healthcare Systems
Karin Moore – Johnson & Johnson Healthcare Systems
So, we all know that there are many changes coming from the healthcare reform bills. But are you aware of the increased scrutiny and additional resources that will be available to the government in an effort to ensure that these regulations are enforced?
This increase in oversight means that you not only need to be more diligent with your compliance, but that you need to convey that message to the other departments of your company. These departments may include ones that you have not found the need to communicate with in the past.
First and foremost you should become best friends with your regulatory group. If CMS determines that your product is or is not one of the pediatric drugs with the rebate percentage that goes alone with it, you should make sure that your regulatory group agrees. Your company may see your product differently than CMS and communication between the two of you will have to be opened. Same situation with an orphan drug; does your company view of the drug category pool equal to where CMS has classified it?
Getting together with your staff that is in charge of processing sales to discuss COT is imperative. They may have one way of classifying returns/reversals that makes sense to their department and to the person who processes the financial data into the company GL. But when it comes to your GP calculations their designation may cause you to inadvertently treat that transaction erroneously in the calculations.
Most importantly, whomever in your company maintains your products within the FDA database – get to know them and make sure they understand how important that database compliance is to CMS. This annually updated information is now one of the ways that CMS checks your products for how they are used and how they are packaged. To head off issues it is best to check that data and continue to ensure that it is accurate as you move forward.
Happy Processing!
About Us
Health Care Insights - From Policy to Practice is the trusted source for news and commentary from the nation's leading Health Care Events such as Medicaid Drug Rebate Program Summit (MDRP), Medicaid Managed Care Congress (MMCC), FDA/CMS to inform Health Plans and Pharmaceutical Manufacturers on the latest developments on Medicare, Medicaid Managed Care, Government Programs, and Health Insurance Exchanges.
Topics we cover include reform, best business practices, the latest innovations, and novel payment models.
Subscribe
Blog Archive
-
▼
2010
(111)
-
▼
September
(23)
- GP Jeopardy at IIR!
- MDRP 2010 Conference - Minimizing Revenue Leakage ...
- MDRP 2010 Conference - Best Practices in Bundling ...
- MDRP 2010 Conference - New Strategies and Opportun...
- MDRP 2010 Conference - Enforcement of the Federal ...
- MDRP 2010 Conference - 340B Pricing Structure and ...
- MDRP 2010 Conference - Successful Rebate Processin...
- MDRP 2010 Conference - Government Pricing Program ...
- MDRP 2010 Conference - Navigating the Operational ...
- MDRP 2010 Conference - State Price Reporting Laws ...
- MDRP 2010 Conference - Current CMS Rebate Data, Op...
- MDRP 2010 Conference - Translating the GP Impact o...
- MDRP 2010 Conference - Translating the Impact of H...
- MDRP 2010 Conference - Reforming Medicaid: Coverin...
- MDRP 2010 Conference - Operational and System Answers
- MDRP 2010 Conference - Estimating and Operationizi...
- MDRP 2010 Conference - Operational Process for the...
- MDRP 2010 Conference - Quantifying the Impact of t...
- MDRP 2010 Conference - Continuing Challenges from ...
- MDRP 2010 Conference - AMP after HCR: Implementati...
- 8th Annual Medicare Congress Brochure Ready for Do...
- Model health care sites opening across the nation
- Are you concerned about the influx of Medicaid Man...
-
▼
September
(23)
No comments:
Post a Comment